Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer

  1. Garassino, M.C.
  2. Paz-Ares, L.
  3. Hui, R.
  4. Faivre-Finn, C.
  5. Spira, A.
  6. Planchard, D.
  7. Özgüroǧlu, M.
  8. Daniel, D.
  9. Vicente, D.
  10. Murakami, S.
  11. Langer, C.
  12. Senan, S.
  13. Spigel, D.
  14. Rydén, A.
  15. Zhang, Y.
  16. O'brien, C.
  17. Dennis, P.A.
  18. Antonia, S.J.
Aldizkaria:
Future Oncology

ISSN: 1744-8301,  1479-6694

Argitalpen urtea: 2021

Alea: 17

Zenbakia: 10

Orrialdeak: 1165-1184

Mota: Artikulua

DOI: 10.2217/FON-2020-1102 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus